This study expands and updates through 1995 our earlier report on influenza vaccine use in 18 developed countries.
Five of the six countries with high levels of vaccine use in 1992 (=130 doses/1000 population) showed little change or slight declines over the subsequent 3 years.
The exception was the United States where a new federal program for vaccination reimbursement for the elderly helped to increase vaccine distribution from 144 to 239 doses/1000 population.
The six countries with medium levels of vaccine use in 1992 (76-96 doses/1000 population) increased to =100 doses/1000 population by 1995.
Among the six low-use countries in 1992 (¾65 doses/1000 population), only Finland showed substantial improvement (96 doses/1000 population) in 1995.
Four new countries were added to the study.
In Germany, vaccine use increased to 80 doses/1000 population in 1995, but in Ireland it remained at a low level (48 doses/1000 population).
In Korea, vaccine use increased from 17 to 95 doses/1000 population during the period 1987-1995.
In Japan, very high levels of vaccine use (280 doses/1000 population) in the early 1980s were associated with vaccination programs for school children.
However, vaccine use fell precipitously when these programs were discontinued, and only 2 and 8 doses/1000 population were used in 1994 and 1995, respectively. (...)
Mots-clés Pascal : Homme, Grippe, Virose, Infection, Vaccination, Programme sanitaire, Immunoprophylaxie, Pays industrialisé, Bilan, Statistique
Mots-clés Pascal anglais : Human, Influenza, Viral disease, Infection, Vaccination, Sanitary program, Immunoprophylaxis, Industrialized country, Balance, Statistics
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0527068
Code Inist : 002B05A02. Création : 13/02/1998.